4.4 Article

A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history

期刊

HUMAN PATHOLOGY
卷 46, 期 12, 页码 1962-1969

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.humpath.2015.08.013

关键词

Papillary thyroid cancer; RET gene; RET/PTC rearrangement; RET/PTC1ex9; Fused gene; Next-generation sequencing

资金

  1. Ministry of Health of the Czech Republic [NT 13901-4]
  2. DRO (EU) [00023761]
  3. Charles University in Prague [SVV UK 260148/2015]

向作者/读者索取更多资源

Papillary thyroid carcinoma (PTC) is the most frequent type of thyroid cancer. Its development is often caused by the formation of RET/PTC fused genes. RET/PTC1 is the most prevalent form, where exon 1 of CCDC6 gene is fused with the intracellular portion of RET protooncogene starting with exon 12. We have discovered a novel RET/PTC1 variant which we have named RET/PTC1 ex9 in metastatic PTC of 8-year-old boy. RET/PTC1 ex9 detection was performed by real-time polymerase chain reaction with melting curve analysis and subsequent Sanger and next-generation sequencing. A fusion of exon 1 of CCDC6 with exon 9 of extracellular domain of RET followed by exon 12 of RET was revealed. This is the first RET/PTC variant among PTC cases that contain the extracellular part of RET. This observation could be probably explained by incorrect splicing of RET due to the somatic 32-bp deletion in exon-intron 11 boundary of RET. (C) 2015 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据